YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

First big depression advance since Prozac nears FDA approval

Posted online

A drug that's said to be the biggest advance in treating depression since the introduction of Prozac in 1987 is nearing approval by the U.S. Food and Drug Administration.

Johnson & Johnson’s esketamine, a close chemical cousin of the anesthetic ketamine, on Thursday was recommended by a panel of outside experts.

The fast-acting antidepressant is administered through a nasal spray.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
From the Ground Up: Willard Central Elementary School safe room and additions

A safe room and classroom addition at Willard Central Elementary School will be used by the music, arts and athletic programs for a district that had 4,536 students last year, according to Missouri Department of Elementary and Secondary Education figures, but school officials say enrollment is projected to grow.

Most Read
Update cookies preferences